Alpha-1 Antitrypsin Deficiency-Associated Clinical Manifestations and Healthcare Resource Use in the United States
Pulmonary events (PEs) associated with alpha-1 antitrypsin deficiency (AATD) can have a severe clinical course and increase healthcare resource use (HRU). However, AATD-associated HRU and healthcare costs have not been extensively described. This study describes and compares real-world HRU and healt...
Saved in:
Main Authors: | Ernesto Mayen Herrera, Corey Joseph, Emily S. Brouwer, Vivek Gandhi, Michael Czorniak |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-05-01
|
Series: | COPD |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/15412555.2021.1917532 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alpha-1 antitrypsin deficiency-associated panniculitis: a case report
by: Špela But, et al.
Published: (2025-06-01) -
PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01) -
Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016-12-01) -
Alpha-1 Antitrypsin Deficiency and Bronchial Asthma: Current Challenges
by: José Luis Lopez-Campos, et al.
Published: (2025-06-01) -
Alpha-1 antitrypsin in COVID-19 patients: a dual-center screening study in Malaysia
by: Norsyuhadah Musa, et al.
Published: (2025-07-01)